Evidence map›Paper›PMID 41484559›Full record

ArticleBMC medical imaging2026

Hybrid 2D/3D CNN and radiomics model for brain tumor classification using EfficientNetb0 and ResNet-18.

Milad Taleb, Sanaz Alibabaei

Abstract read
In one paragraph

Article in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Milad TalebDepartment of Computer Engineering, K.N. Toosi University of Technology, Tehran, Iran.
Sanaz AlibabaeiMedical Physics Department, Faculty of Medicine, Semnan University of Medical Science, Semnan, Iran. sanazalibabaei994@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Brain tumors, caused by rapid and uncontrolled cellular proliferation, pose significant health risks worldwide. Accurate and early classification of tumor types such as Glioblastoma, IDH-wildtype, grade 4, Meningioma, and Brain Metastasis is crucial for improving treatment outcomes. This study combines Radiomic features with advanced deep learning models, including EfficientNet-B0 and ResNet-18, to classify 2D and 3D brain tumor images effectively. The classifiers, particularly MLP and CatBoost, demonstrated robust performance, achieving macro F1-scores of 86% and 84%, respectively. However, the imbalanced dataset posed challenges in classification accuracy for less represented classes, emphasizing the need for comprehensive evaluation using AUC and ROC analyses. Additionally, SHAP analysis revealed that texture heterogeneity features, especially original_gldm_DependenceNonUniformityNormalized, consistently contributed significantly across tumor types. Model uncertainty assessment showed that brain metastasis was the most confidently predicted class in both models, meningioma classification had higher confidence in MLP, and Glioblastoma, IDH-wildtype was predicted more reliably by CatBoost. These findings highlight the complementary strengths of combining Radiomics and deep learning for enhanced brain tumor classification and underscore the value of uncertainty quantification in model evaluation.

Indexed as

Brain NeoplasmsDeep LearningClassification AlgorithmsConvolutional Neural NetworksHumansImaging, Three-DimensionalMagnetic Resonance ImagingMeningiomaRadiomicsBrain metastaticClassificationDeep learningGlioblastomaIDH-wildtypeMachine learningMeningioma

Identifiers

PMID41484559
PMCPMC12866514

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.